seed
Stage
2018
Founded
1
Investors
About
Deepeye Medical develops AI-driven therapy planning support for retinal diseases, specifically targeting neovascular age-related macular degeneration (nAMD). Their platform provides predictive insights to optimize treatment regimens and improve patient outcomes.
Explore Deepeye Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.